Every 10-Q that BellRing Brands, Inc. (BRBR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BRBR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BRBR filings page.
BellRing Brands, Inc. reported softer fiscal Q2 2026 results. Net sales rose modestly to $598.7 million, up 2%, but operating profit fell to $66.0 million and net earnings dropped to $33.9 million, down about 42% from a year earlier.
Profitability was pressured by lower average net selling prices for Premier Protein, higher raw material, manufacturing and freight costs, and an $11.3 million inventory charge on a third‑party ingredient that failed quality standards. Higher advertising spending and increased interest expense from greater Revolving Credit Facility borrowings also weighed on results.
For the first six months, net sales grew 1% to $1,136.0 million, while net earnings fell to $77.6 million. Operating cash flow swung to an outflow of $14.3 million due to lower earnings and working capital movements, partly offset by smaller inventory builds and lower tax payments.
BellRing Brands, Inc. reported net sales of $537.3 million for the quarter ended December 31, 2025, up 1% from a year earlier. Growth in Dymatize products offset slightly lower Premier Protein sales.
Operating profit fell to $78.5 million, down 32%, as higher raw material and manufacturing costs compressed margins despite lower advertising spend. Net earnings declined to $43.7 million, a 43% drop, and diluted EPS decreased to $0.36.
Inventories rose sharply to $435.2 million, and total debt increased to $1.19 billion, including 7.00% senior notes and higher revolving credit borrowings. The company repurchased 3.0 million shares for $97.8 million and remained in compliance with leverage covenants.
BellRing recorded an estimated liability of $88.0 million related to Joint Juice class action settlements and outlined preliminary New York and multistate settlement terms. A new putative securities class action was filed, and the CEO announced a planned retirement with a multi‑year advisory role and equity-based transition package.
BellRing Brands (BRBR) Q3 FY25 (ended 6/30/25) 10-Q highlights
- Sales growth but profit hit: Net sales rose 6% YoY to $547.5 m, led by Premier Protein (+6%) and Dymatize (+5%). However, a $68.1 m litigation provision pushed SG&A to $144.5 m, slashing operating profit 60% to $44.8 m and diluted EPS 71% to $0.16.
- Margin pressure: Gross margin slipped 140 bp to 35.4% on higher raw-material and manufacturing costs. Operating margin fell from 21.7% to 8.2%.
- Nine-month view: Revenue up 16% to $1.67 bn, but EPS down 8% to $1.21 as inflation and legal costs offset volume gains.
- Balance-sheet shifts: Inventories +45% YoY to $415.6 m; cash down 38% to $43.7 m. Debt increased to $1.01 bn after $175 m revolver draw; net leverage covenant remains <6×.
- Capital returns: Repurchased 3.8 m shares for $267.6 m YTD; treasury stock now $566.6 m.
- Legal overhang: Total accrual for Joint Juice litigation raised to $90 m; class-wide settlement in principle reached, pending court approval.
- Cash flow: Operating cash fell 43% to $91.5 m, mainly from inventory build and higher receivables.
- Outlook items: Management cites continuing input-cost inflation and is evaluating July 2025 U.S. tax law changes; no quantitative guidance provided.